Classification of current anticancer immunotherapies.

During the past decades, anticancer immunotherapy has evolved from a promising therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now approved by the US Food and Drug Administration and the European Medicines Agency for use in cancer patients, and many others are be...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Galluzzi, L, Vacchelli, E, Bravo-San Pedro, J, Buqué, A, Senovilla, L, Baracco, E, Bloy, N, Castoldi, F, Abastado, J, Agostinis, P, Apte, R, Aranda, F, Ayyoub, M, Beckhove, P, Blay, J, Bracci, L, Caignard, A, Castelli, C, Cavallo, F, Celis, E, Cerundolo, V, Clayton, A, Colombo, M, Coussens, L, Dhodapkar, M
التنسيق:	Journal article
اللغة:	English
منشور في:	2014

Classification of current anticancer immunotherapies.

مواد مشابهة